The issuer of the KURE ETF is KraneShares. KraneShares is a renowned provider of China-focused exchange-traded funds (ETFs) and is committed to offering innovative investment solutions to investors seeking exposure to Chinese markets. Established with a strong focus on China's economic growth and the unique investment opportunities it presents, KraneShares has a track record of creating ETFs that track specific sectors and themes within the Chinese economy. The KURE ETF, in particular, seeks to replicate the performance of a specialized index that measures the equity market performance of Chinese companies in the healthcare sector, aligning with KraneShares' dedication to providing targeted investment options for investors interested in China's dynamic markets.
The KraneShares MSCI All China Health Care Index ETF (KURE) is primarily focused on tracking the performance of Chinese companies in the healthcare sector. While its primary objective is not dividend-centric, KURE's dividend distribution is influenced by the dividend policies and performances of the constituent companies within its underlying index. These dividends are typically distributed on a periodic basis, and KURE aims to invest at least 80% of its net assets in instruments related to its Underlying Index, which is rebalanced quarterly. Investors considering KURE may benefit from potential capital appreciation alongside dividend returns, as it includes a mix of mid-cap and large-cap companies within the healthcare sector in China.
KURE, the KraneShares MSCI All China Health Care Index ETF, tracks the performance of the MSCI All China Health Care 10/40 Index. The fund primarily invests at least 80% of its assets in instruments that are part of its underlying index, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The index includes various types of publicly issued shares of Chinese issuers, such as A-Shares, B-Shares, H-Shares, P-Chips, Red Chips, and S-Chips, covering mid-cap and large-cap companies.
The correlation aspect of the KraneShares MSCI All China Health Care Index ETF (KURE) is crucial in understanding its performance in relation to the Chinese healthcare sector. As KURE seeks to track the MSCI All China Health Care Index, it tends to exhibit a strong correlation with the performance of Chinese healthcare companies. This correlation makes KURE a valuable tool for investors looking to gain exposure to this specific sector within the Chinese market. To delve deeper into KURE's correlations with other assets and sectors, ETF Insider offers a user-friendly web app with visualization tools that provide valuable insights and help investors identify overlaps for effective portfolio management and decision-making.
The KraneShares MSCI All China Health Care Index ETF (KURE) is primarily involved in the healthcare sector in China. This ETF is designed to track the performance of Chinese companies within the healthcare sector, as classified by the Global Industry Classification Standard. KURE offers exposure to various segments of the healthcare industry in China, including pharmaceuticals, biotechnology, medical equipment, and more. It provides investors with an opportunity to capitalize on the growth potential of the Chinese healthcare sector, which is undergoing significant development and innovation. However, as it focuses solely on healthcare, it may carry sector-specific risks and may not be as diversified as other ETFs.
The exposure of the KraneShares MSCI All China Health Care Index ETF (KURE) is centered on the Chinese healthcare sector. This ETF seeks to replicate the performance of the MSCI All China Health Care 10/40 Index, focusing on Chinese healthcare companies. KURE provides investors with access to the healthcare market in China, which includes companies involved in pharmaceuticals, biotechnology, medical equipment, and related segments. To gain a deeper understanding of KURE's exposure and discover more detailed information about this ETF, ETF Insider's web app offers comprehensive data and visualization tools, allowing investors to analyze correlations, overlaps, and other key factors in their investment decision-making process.
ETF Insider is a data-driven portfolio analytics and optimization platform that introduces a more efficient and practical way to visualize, analyze and optimize portfolios.
Rather than focusing on the surface-level attributes of ETFs and Mutual Funds, ETF Insider goes deeper by examining the underlying holdings of exchange traded products.
By organizing and structuring that data, investors can easily navigate within their overlapping layers.
This innovative perspective combined with modern data visualization and modeling tools, provides an entirely new approach to portfolio optimization that can quickly expose both portfolio inefficiencies and opportunities.
3 min readCompare the XLK and BOTZ ETFs with our thorough analysis. Dive into the performance metrics, underlying assets, and investment strategies to see how they stack up against each other. Whether you're a seasoned investor or just getting started, our comparison provides valuable insights to guide your investment decisions.
4 min readLEGR VS bitq are specialized investment funds that focus on a diverse range of sectors in the financial market. these exchange-traded funds offer investors exposure to various industries and companies, presenting potential growth opportunities and risks. it's essential to understand the underlying assets and strategies of these etfs before considering an investment.
6 min readThe KURE ETF is a specialized investment fund that focuses on a specific sector. This exchange-traded fund offers investors exposure to a range of companies in this sector.
ETF Insider is a novel portfolio optimization tool that uses the power of data visualization to gain insight into portfolio compositions, concentration risks, portfolio efficiency and more. Complex financial data can be transformed into visually appealing and easily digestible graphs and charts, allowing investors to quickly identify trends and make well-informed investment decisions. Not only does this save time, but it also increases the accuracy and effectiveness of portfolio management.
